These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31763930)

  • 1. The Relationships of High-Sensitivity C-Reactive Protein and Homocysteine Levels With Disease Activity, Damage Accrual, and Cardiovascular Risk in Systemic Lupus Erythematosus.
    Pocovi-Gerardino G; Correa-Rodríguez M; Rubio JC; Fernández RR; Amada MM; Caparros MC; Rueda-Medina B; Ortego-Centeno N
    Biol Res Nurs; 2020 Apr; 22(2):169-177. PubMed ID: 31763930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary Intake of Free Sugars is Associated with Disease Activity and Dyslipidemia in Systemic Lupus Erythematosus Patients.
    Correa-Rodríguez M; Pocovi-Gerardino G; Callejas-Rubio JL; Ríos Fernández R; Martín-Amada M; Cruz-Caparros MG; Medina-Martínez I; Ortego-Centeno N; Rueda-Medina B
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32326626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of obesity on disease activity, damage accrual, inflammation markers and cardiovascular risk factors in systemic lupus erythematosus.
    Correa-Rodríguez M; Pocovi-Gerardino G; Callejas Rubio JL; Ríos Fernández R; Martín Amada M; Cruz Caparrós M; Ortego-Centeno N; Rueda-Medina B
    Panminerva Med; 2020 Jun; 62(2):75-82. PubMed ID: 32515571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine, folate, hs-C-reactive protein, tumor necrosis factor alpha and inflammatory proteins: are these biomarkers related to nutritional status and cardiovascular risk in childhood-onset systemic lupus erythematosus?
    Salomão RG; de Carvalho LM; Izumi C; Czernisz ÉS; Rosa JC; Antonini SRR; Bueno AC; Almada MORDV; Coelho-Landell CA; Jordão AA; Ferriani VPL; Monteiro JP
    Pediatr Rheumatol Online J; 2018 Jan; 16(1):4. PubMed ID: 29316941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Correlation Between Serum Hcy Level and Clinical Indicators in Systemic Lupus Erythematosus Patients].
    Ding XJ; Chen Y; Duan X; Wang L; Liu Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jul; 50(4):619-621. PubMed ID: 31642246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemia in pediatric systemic lupus erythematosus: the relationship with disease activity and plasma homocysteine and cysteine concentrations.
    Ortiz TT; Terreri MT; Caetano M; Souza FS; D'Almeida V; Sarni RO; Hilário MO
    Ann Nutr Metab; 2013; 63(1-2):77-82. PubMed ID: 23942034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort.
    Ardoin SP; Schanberg LE; Sandborg C; Yow E; Barnhart HX; Mieszkalski Kl; Ilowite NT; von Scheven E; Eberhard A; Levy DM; Kimura Y; Silverman E; Bowyer SL; Punaro L; Singer NG; Sherry DD; McCurdy D; Klein-Gitelman M; Wallace C; Silver R; Wagner-Weiner L; Higgins GC; Brunner HI; Jung LK; Imundo L; Soep JB; Reed AM;
    Lupus; 2010 Oct; 19(11):1315-25. PubMed ID: 20861207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damage.
    Bertoli AM; Vilá LM; Reveille JD; Alarcón GS;
    J Rheumatol; 2008 Dec; 35(12):2355-8. PubMed ID: 19004040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel cardiovascular risk factors and cardiac event predictors in female inactive systemic lupus erythematosus patients.
    Karadag O; Calguneri M; Atalar E; Yavuz B; Akdogan A; Kalyoncu U; Bilgen SA; Ozer N; Ertenli AI; Ovunc K; Kiraz S
    Clin Rheumatol; 2007 May; 26(5):695-9. PubMed ID: 16909327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
    Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effect of Mediterranean diet on disease activity and cardiovascular risk in systemic lupus erythematosus patients: a cross-sectional study.
    Pocovi-Gerardino G; Correa-Rodríguez M; Callejas-Rubio JL; Ríos-Fernández R; Martín-Amada M; Cruz-Caparros MG; Rueda-Medina B; Ortego-Centeno N
    Rheumatology (Oxford); 2021 Jan; 60(1):160-169. PubMed ID: 32594173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease.
    Youssef MY; Mojiminiyi OA; Abdella NA
    Transl Res; 2007 Sep; 150(3):158-63. PubMed ID: 17761368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibodies to N-homocysteinylated albumin in patients with systemic lupus erythematosus].
    Padjas A; Undas A; Swadzba J; Musiał J
    Pol Arch Med Wewn; 2007 Mar; 117(3):20-5. PubMed ID: 17718048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk.
    Barnes EV; Narain S; Naranjo A; Shuster J; Segal MS; Sobel ES; Armstrong AE; Santiago BE; Reeves WH; Richards HB
    Lupus; 2005; 14(8):576-82. PubMed ID: 16175928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort.
    Zeña-Huancas PA; Iparraguirre-López H; Gamboa-Cárdenas RV; Reátegui-Sokolova C; Zevallos-Miranda F; Medina-Chinchon M; Pimentel-Quiroz VR; Elera-Fitzcarrald C; Sarmiento-Velasquez O; Cucho-Venegas JM; Alfaro-Lozano JL; Rodríguez-Bellido ZJ; Pastor-Asurza CA; Perich-Campos RA; Alarcón GS; Ugarte-Gil MF
    Clin Rheumatol; 2019 Apr; 38(4):1139-1146. PubMed ID: 30539353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining serum biomarkers: the association of C-reactive protein, insulin sensitivity, and homocysteine with cardiovascular disease history in the general US population.
    Cummings DM; King DE; Mainous AG; Geesey ME
    Eur J Cardiovasc Prev Rehabil; 2006 Apr; 13(2):180-5. PubMed ID: 16575270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated circulating homocysteine and high-sensitivity C-reactive protein jointly predicts post-stroke depression among Chinese patients with acute ischemic stroke.
    Yin J; Zhong C; Zhu Z; Bu X; Xu T; Guo L; Wang X; Zhang J; Cui Y; Li D; Zhang J; Ju Z; Chen CS; Chen J; Zhang Y; He J
    Clin Chim Acta; 2018 Apr; 479():132-137. PubMed ID: 29325799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk assessment and homocysteine and leptin levels in peritoneal dialysis and hemodialysis patients.
    Bekpinar S; Unlüçerçi Y; Genç S; Türkmen A
    Adv Perit Dial; 2005; 21():80-4. PubMed ID: 16686291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of cardiometabolic risk status with clinical activity and damage in systemic lupus erythematosus patients: A cross-sectional study.
    Campos-López B; Meza-Meza MR; Parra-Rojas I; Ruiz-Ballesteros AI; Vizmanos-Lamotte B; Muñoz-Valle JF; Montoya-Buelna M; Cerpa-Cruz S; Bernal-Hernández LE; De la Cruz-Mosso U
    Clin Immunol; 2021 Jan; 222():108637. PubMed ID: 33232825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.